# Eleven Biotherapeutics, Inc. — Form D/A

Eleven Biotherapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2010-10-13. The offering totals $35.0M, of which $8.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2010-10-13
- Form: D/A
- Accession: 0001485003-10-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $35.0M
- Amount sold: $8.8M
- Remaining: $26.3M
- Investors: 3
- Date of first sale: 2010-02-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-138996

## Issuer

- Name: Eleven Biotherapeutics, Inc.
- CIK: 0001485003
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 245 FIRST STREET, CAMBRIDGE, MA, 02142
- Phone: 617-444-8550

## Officers, directors & promoters (32)

_Showing 25 of 32 people._

| Name | Role | Location |
| --- | --- | --- |
| Noubar B Afeyan | Director | Cambridge, MA |
| David M Berry | Director | Cambridge, MA |
| Mark Levin | Director | New York, NY |
| Cary B Pfeffer | Director | Cambridge, MA |
| Kim C Drapkin | Executive Officer | Boston, MA |
| Mark Levin | Executive Officer | New York, NY |
| Cary B Pfeffer | Executive Officer | Cambridge, MA |
| Gregory D Perry | Executive Officer | Arlington, MA |
| Cary G Pfeffer | Director | Baltimore, MD |
| Daniel S Lynch | Director | Cambridge, MA |
| Barry J Gertz | Director | Cambridge, MA |
| Richard F Fitzgerald | Executive Officer | Cambridge, MA |
| Leslie G Dan | Director | Cambridge, MA |
| Jane V Henderson | Director | Cambridge, MA |
| Paul G Chaney | Director | Cambridge, MA |
| Stephen A Hurly | Director | Cambridge, MA |
| Stephen A Hurly | Executive Officer | Cambridge, MA |
| Abbie C Celniker | Director | Cambridge, MA |
| Jay S Duker | Director | Cambridge, MA |
| Stephen V Hurly | Director | Cambridge, MA |
| Stephen V Hurly | Executive Officer | Cambridge, MA |
| John C McCabe | Executive Officer | Cambridge, MA |
| Abbie C Celniker, Ph.D. | Director | Cambridge, MA |
| Abbie C Celniker, Ph.D. | Executive Officer | Cambridge, MA |
| Leslie V Dan | Director | Cambridge, MA |

## Other filings by this issuer (4)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2018-04-05](https://search.stillhousedata.com/formd/0001140361-18-017371) | D | $996K | $996K |
| [2016-09-28](https://search.stillhousedata.com/formd/0001485003-16-000183) | D | $13.5M | $13.5M |
| [2014-12-05](https://search.stillhousedata.com/formd/0001485003-14-000002) | D | $20.0M | $20.0M |
| [2010-02-24](https://search.stillhousedata.com/formd/0001485003-10-000001) | D | $35.0M | $4.5M |

## More

- [CIK 1485003 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1485003&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001485003-10-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.